Companies Brace for Supreme Court Ruling on Affirmative Action

Decisions on race-conscious college admissions may have implications for corporate diversity programs.

WSJ News Exclusive | Merck deal for Seasons seen as unlikely by earnings release

Merck Nearly $40 billion deal for & Co. season Inc. is unlikely to be finalized before…

WSJ News Exclusive | Merck deal for Seasons seen as unlikely by earnings release

Merck Nearly $40 billion deal for & Co. season Inc. is unlikely to be finalized before…

Pharma has a hiding place during recession

As pharma companies begin reporting earnings next week, investors could be forgiven for paying more attention…

WSJ News Exclusive | Merck is in advanced talks to buy Cezanne

Merck & Co in advanced talks for acquisition season And according to people familiar with the…

WSJ News Exclusive | Merck in advanced talks to buy Seagen for roughly $40 billion or more

Merck & Co in advanced talks for acquisition season and aiming to agree to a purchase…

Investment Banks Prepare for Lean Times as Deal Spree Sputters

Wall Street’s latest deal-making boom began to weaken in 2022. The industry is set for a…

Big Pharma will not grant bail to battered biotech

Share Market It may have been in a recession, but the Biotechnology Index has fallen off…

The supply of effective COVID antibody drug in the US is dwindling

Federal government stores of a key COVID-19 antibody drug, a key weapon to keep the infected…

WSJ News Exclusive | Merck moves forward with potential deal for Seasonale

According to people familiar with the matter, Merck & Co. is moving forward with a potential…